Innate Pharma Stock
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.002 (0.130%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.130% | -1.589% | -7.009% | -13.403% | -2.876% | -59.816% | -61.140% |
| Transgene S.A. | -2.300% | -7.327% | 4.464% | 31.276% | -3.106% | -52.535% | -54.341% |
| Nanobiotix | 0.330% | 1.336% | -2.045% | 528.019% | -4.712% | 367.866% | 14.610% |
| Valneva SE | 0.560% | 1.971% | 21.600% | 110.562% | 15.217% | -39.420% | -56.496% |
